Cite
Point-of-care quantification of serum cellular fibronectin levels for stratification of ischemic stroke patients.
MLA
Fernandes, Elisabete, et al. “Point-of-Care Quantification of Serum Cellular Fibronectin Levels for Stratification of Ischemic Stroke Patients.” Nanomedicine: Nanotechnology, Biology & Medicine, vol. 30, Nov. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.nano.2020.102287.
APA
Fernandes, E., Sobrino, T., Martins, V. C., Lopez-loureiro, I., Campos, F., Germano, J., Rodríguez-Pérez, M., Cardoso, S., Petrovykh, D. Y., Castillo, J., & Freitas, P. P. (2020). Point-of-care quantification of serum cellular fibronectin levels for stratification of ischemic stroke patients. Nanomedicine: Nanotechnology, Biology & Medicine, 30, N.PAG. https://doi.org/10.1016/j.nano.2020.102287
Chicago
Fernandes, Elisabete, Tomás Sobrino, Verónica C. Martins, Ignacio Lopez-loureiro, Francisco Campos, José Germano, Manuel Rodríguez-Pérez, et al. 2020. “Point-of-Care Quantification of Serum Cellular Fibronectin Levels for Stratification of Ischemic Stroke Patients.” Nanomedicine: Nanotechnology, Biology & Medicine 30 (November): N.PAG. doi:10.1016/j.nano.2020.102287.